Business Context and Reporting Period
This Form 8-K filing by Palisade Bio, Inc. (PALI) reports a corporate action effective April 5, 2024. The Company, incorporated in Delaware and headquartered in Carlsbad, California, announced the implementation of a reverse stock split of its common stock.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company executed a 1-for-15 reverse stock split of its common stock.
- Share Count Reduction: Issued and outstanding shares decreased from 12,771,015 to approximately 851,401 shares.
- Authorized Shares: The number of authorized common and preferred shares remains unchanged at 280,000,000 and 7,000,000, respectively.
- Adjustments to Securities: Outstanding stock options, warrants, and convertible securities were adjusted proportionately (shares reduced, exercise/conversion prices increased).
- Fractional Shares: No fractional shares were issued; holders received cash in lieu of fractional interests based on the April 5, 2024 closing price.
- Preferred Stock: The conversion price for Series A 4.5% Convertible Preferred Stock was proportionately adjusted.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard qualification that the information is subject to the terms of the Amendment to the Certificate of Incorporation. The primary operational change is the commencement of post-split trading on the Nasdaq Capital Market under the symbol "PALI" on April 8, 2024, with a new CUSIP number (696389402).
Investor Verification Checklist
- Verify the new CUSIP number (696389402) for post-split trading.
- Confirm the adjusted share count and exercise prices for any held options or warrants.
- Check the cash payout received for any fractional shares resulting from the 1-for-15 split.
- Review the Amendment to the Amended and Restated Certificate of Incorporation (Exhibit 3.01(i)) for specific legal terms.